A dozen states are suing a drug manufacturer and three drug distributors for more than $26 billion. Why? So they can restore the lives and mop up the wreckage left by the opioid epidemic.
The maker of OxyContin, Purdue Pharma, has agreed to plead guilty to three federal criminal charges for its role in creating and advancing the nation's opioid epidemic. Unfortunately, this does not even come close to holding Purdue accountable for the damage it caused.
A cursory glance at recent headlines will reveal story after story of huge, multi-billion dollar pharma companies being sued for the part they played in the creation of the opiate epidemic. Now the cat is out of the bag, one could say, and the American public knows the truth.
In August 2019, Cleveland County Judge Thad Balkman ordered Johnson & Johnson and their subsidiary, Janssen Pharmaceuticals to pay Oklahoma $572 million for the harm their products cause. When the settlement is paid, what will the benefits actually be? Will Oklahomans actually benefit?
One of the most common questions I hear regarding addiction is, “How did the addiction epidemic get so bad?” And I can see why people ask this.
According to a Washington Post article published February 2015, the United States and New Zealand are the only two countries that allow direct to consumer advertising for pharmaceutical products.
In 2012, the Senate Finance Committee opened an investigation that could have revealed a hidden influence contributing to the loss of thousands of American lives. IF the report on this investigation had ever been published.
In state after state, Attorneys General have been filing lawsuits directed at pharmaceutical corporations they claim are responsible for our current epidemic of opioid abuse and addiction. What benefits could result if these lawsuits are won?
As President Donald Trump declared a public health emergency, authorities in Arizona arrested John Kapoor, the founder of Insys Therapeutics for criminal tactics in promoting the use of a fentanyl spray.